|
|
 |
|
Viewing report
|
|
|
|
Beth Israel Medical Center - Developmental Therapeutics Review - Q4 2010
Global Markets Direct, Dec 2010, Pages: 33
Beth Israel Medical Center – Developmental Therapeutics Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Beth Israel Medical Center - Developmental Therapeutics Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Beth Israel Medical Center - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Beth Israel Medical Center human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Beth Israel Medical Center with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Beth Israel Medical Center’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Beth Israel Medical Center - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Beth Israel Medical Center human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Beth Israel Medical Center with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Beth Israel Medical Center’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
|
|
|
|
